{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:29:47Z","timestamp":1791221387977,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013642","name":"Japan Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"Senshin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004042","name":"Kanagawa Institute of Industrial Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24bm1123010"],"award-info":[{"award-number":["24bm1123010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018456","name":"Kanagawa Institute of Industrial Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008695","name":"Japan Foundation for Applied Enzymology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K27683"],"award-info":[{"award-number":["23K27683"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15140"],"award-info":[{"award-number":["23K15140"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.stem.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:11:32Z","timestamp":1784214692000},"page":"1339-1353.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human iPSC-derived engineered heart tissue model of diastolic dysfunction in heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"33","author":[{"given":"Hidenori","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijun","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uikyu","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Momoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko C.","family":"Umei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuika","family":"Morita-Umei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitsu","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-3543","authenticated-orcid":false,"given":"Shugo","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2026.06.007_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14336\/AD.2022.0523","article-title":"The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies","volume":"14","author":"Cai","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.stem.2026.06.007_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction","volume":"126","author":"Van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-50312-1","article-title":"Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice","volume":"15","author":"Weng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCIMAGING.110.961979","article-title":"Extrapolation from mouse to man","volume":"4","author":"Hamlin","year":"2011","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.stem.2026.06.007_bib6","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.stem.2020.10.013","article-title":"Capturing Cardiogenesis in Gastruloids","volume":"28","author":"Rossi","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41551-023-01134-x","article-title":"Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction","volume":"8","author":"Tu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.stem.2026.06.007_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.stemcr.2024.01.003","article-title":"ER stress and lipid imbalance drive diabetic embryonic cardiomyopathy in an organoid model of human heart development","volume":"19","author":"Kostina","year":"2024","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2026.06.007_bib10","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","article-title":"Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.855763","article-title":"Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery","volume":"10","author":"Tani","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.stem.2026.06.007_bib12","first-page":"211","article-title":"US agency seeks to phase out animal testing","volume":"611","author":"Nuwer","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.06.007_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.06.007_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21931-9","article-title":"Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction","volume":"12","author":"Schiattarella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD+ Repletion Reverses Heart Failure with Preserved Ejection Fraction","volume":"128","author":"Tong","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"12","author":"Tohyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cmet.2016.03.001","article-title":"Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells","volume":"23","author":"Tohyama","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.stem.2026.06.007_bib18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","article-title":"Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes","volume":"9","author":"Tohyama","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2026.06.007_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122174","article-title":"Heart-derived collagen promotes maturation of engineered heart tissue","volume":"299","author":"Tani","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.stem.2026.06.007_bib20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.06.007_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.06.007_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41587-019-0197-9","article-title":"Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration","volume":"37","author":"Bargehr","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2026.06.007_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43312-0","article-title":"Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells","volume":"14","author":"Fernandes","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40610-017-0066-6","article-title":"Harnessing Epicardial Progenitor Cells and Their Derivatives for Rescue and Repair of Cardiac Tissue After Myocardial Infarction","volume":"3","author":"Rao","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"key":"10.1016\/j.stem.2026.06.007_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nbt.3002","article-title":"Generation of the epicardial lineage from human pluripotent stem cells","volume":"32","author":"Witty","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2026.06.007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112322","article-title":"Vascular cells improve functionality of human cardiac organoids","volume":"42","author":"Voges","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.stem.2026.06.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120612","article-title":"Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering","volume":"269","author":"Colzani","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.stem.2026.06.007_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41551-022-00882-6","article-title":"A multi-organ chip with matured tissue niches linked by vascular flow","volume":"6","author":"Ronaldson-Bouchard","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.stem.2026.06.007_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s44161-024-00516-x","article-title":"Myocardial ultrastructure of human heart failure with preserved ejection fraction","volume":"3","author":"Meddeb","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib30","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/cvr\/cvab328","article-title":"Titin (TTN): from molecule to modifications, mechanics, and medical significance","volume":"118","author":"Loescher","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: Contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.stem.2026.06.007_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119741","article-title":"Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing","volume":"233","author":"Mastikhina","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.stem.2026.06.007_bib34","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.stem.2026.06.007_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201601434","article-title":"Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling","volume":"6","author":"Sadeghi","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.stem.2026.06.007_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30630-y","article-title":"Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-\u03b2-IGFBP7 axis","volume":"13","author":"Ko","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib37","article-title":"Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1257283","article-title":"Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a","volume":"2021","author":"Shao","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.stem.2026.06.007_bib39","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/CIRCULATIONAHA.122.062021","article-title":"Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial","volume":"147","author":"Hundertmark","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure","volume":"82","author":"Mentz","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.stem.2026.06.007_bib41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jchf.2023.07.014","article-title":"Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis","volume":"12","author":"Zafeiropoulos","year":"2024","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.stem.2026.06.007_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/ejhf.876","article-title":"Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.stem.2026.06.007_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.stem.2026.06.007_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106931","article-title":"Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment","volume":"196","author":"Mollace","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1\u03b1 Oxidation Suppresses Antihypertrophic\/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ., Heart Fail."},{"key":"10.1016\/j.stem.2026.06.007_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00395-024-01074-w","article-title":"Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction","volume":"119","author":"Lanzer","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.stem.2026.06.007_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jare.2024.02.006","article-title":"Single-cell transcriptomic profiling of heart reveals ANGPTL4 linking fibroblasts and angiogenesis in heart failure with preserved ejection fraction","volume":"68","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin Blunts Worsening Cardiac Dysfunction Associated with Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ., Heart Fail."},{"key":"10.1016\/j.stem.2026.06.007_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108053","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","volume":"236","author":"Toldo","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.stem.2026.06.007_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117711","article-title":"The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mouse model","volume":"181","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.stem.2026.06.007_bib51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting Mitochondria-Inflammation Circuit by \u03b2-Hydroxybutyrate Mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107555","article-title":"Intercellular Mitochondrial transfer: Therapeutic implications for energy metabolism in heart failure","volume":"211","author":"He","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.stem.2026.06.007_bib54","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.stem.2024.05.011","article-title":"Primitive macrophages enable long-term vascularization of human heart-on-a-chip platforms","volume":"31","author":"Landau","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114302","article-title":"Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue","volume":"43","author":"Lock","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.stem.2026.06.007_bib56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s44161-024-00471-7","article-title":"Primitive macrophages induce sarcomeric maturation and functional enhancement of developing human cardiac microtissues via efferocytic pathways","volume":"3","author":"Hamidzada","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib57","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium\/Glucose Cotransporter 2 Inhibitor Empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib58","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/cvr\/cvaa323","article-title":"Off-target effects of sodium-glucose co-transporter 2 blockers: Empagliflozin does not inhibit Na+\/H+ exchanger-1 or lower [Na+]i in the heart","volume":"117","author":"Chung","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cvr\/cvae004","article-title":"Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors","volume":"120","author":"Wijnker","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib60","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial Dysfunction in Heart Failure with Preserved Ejection Fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib61","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.cell.2022.05.024","article-title":"Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses","volume":"185","author":"Ang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.06.007_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-02924-x","article-title":"High-efficient serum-free differentiation of endothelial cells from human iPS cells","volume":"13","author":"Hamad","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stem.2026.06.007_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103494","article-title":"Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells","volume":"6","author":"Loh","year":"2025","journal-title":"Star Protoc."},{"key":"10.1016\/j.stem.2026.06.007_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.123.065517","article-title":"Metabolic Communication by SGLT2 Inhibition","volume":"149","author":"Billing","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.stem.2026.06.007_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp9952","article-title":"SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant","volume":"15","author":"Guo","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2026.06.007_bib66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.stem.2026.06.007_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2023.05.094","article-title":"Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress","volume":"671","author":"Luo","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stem.2026.06.007_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.stem.2026.06.007_bib69","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10557-020-07083-w","article-title":"Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells","volume":"35","author":"Uthman","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.stem.2026.06.007_bib70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1113\/JP283082","article-title":"Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure","volume":"601","author":"Macleod","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.stem.2026.06.007_bib71","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2+ handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib72","first-page":"222","article-title":"Regulation of intracellular Na + in health and disease: pathophysiological mechanisms and implications for treatment","volume":"2013","author":"Coppini","year":"2013","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.stem.2026.06.007_bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2026.06.007_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101360","article-title":"Purification of cardiomyocytes and neurons derived from human pluripotent stem cells by inhibition of de novo fatty acid synthesis","volume":"3","author":"Tanosaki","year":"2022","journal-title":"Star Protoc."},{"key":"10.1016\/j.stem.2026.06.007_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101275","article-title":"Directed differentiation of human pluripotent stem cells to epicardial-derived fibroblasts","volume":"3","author":"Floy","year":"2022","journal-title":"Star Protoc."},{"key":"10.1016\/j.stem.2026.06.007_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","article-title":"Development of a Drug Screening Platform Based on Engineered Heart Tissue","volume":"107","author":"Hansen","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.stem.2026.06.007_bib77","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nprot.2017.033","article-title":"Differentiation of cardiomyocytes and generation of human engineered heart tissue","volume":"12","author":"Breckwoldt","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stem.2026.06.007_bib78","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2026.06.007_bib79","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2026.06.007_bib80","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2026.06.007_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79745-w","article-title":"Optimized simple culture protocol for inducing mature myotubes from MYOD1-overexpressed human iPS cells","volume":"14","author":"Wada","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926002341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926002341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:20:53Z","timestamp":1790166053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590926002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1934590926002341"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2026.06.007","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived engineered heart tissue model of diastolic dysfunction in heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}